Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Apr 6;13(4):527. doi: 10.3390/metabo13040527

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2023 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Graph (A) and Table (B) of brain metabolites on MRS at 4 weeks of age: glutamine (Glu), glutathione (GSH), Myo-inositol (mIns), N-acetyl aspartate (NAA), Taurine (Tau), glycerophosphocholine + phosphocholine (GPC + PCh), N-acetyl aspartate + N-acetyl aspartyl glutamate (NAA + NAAG), creatine + phosphocreatine (Cr + PCr), and glutamine + glutamic acid (Glu + Gln). The results of the comparison between the four-groups (non-treatment, 2.5 × 1, 2.5 × 2, and 2.5 × 4) are shown. Between-group comparisons were analyzed by one-way ANOVA with Tukey’s multiple comparison tests using Prism 9. The results showed no significant difference between the two-dose group (2.5 × 2) and the four-dose group (2.5 × 4). As compared with the non-treatment group: * p < 0.05. As compared with the one-dose FASD group (2.5 × 1): # p < 0.05; ## p < 0.01; ### p < 0.001.